What MADRIGAL PHARMACEUTICALS, INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 5 | 5 |
| Sells | 25 | 178 |
| Total trades | 30 | 209 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 91,806 | 329,050 |
| Disposed | 12,660 | 136,440 |
| Net activity | +79,146 | +192,610 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Kelley Shannon T | General Counsel | Nov 06 | Open-market sale · S | −1,077 | $400.00 | −$431K | 10,397 |
| Baker Bros. Advisors Lp | Director | Nov 06 | Open-market buy · P | +2,000 | $396.61 | +$793K | 2,040,682 |
| Baker Bros. Advisors Lp | Director | Nov 06 | Open-market buy · P | +13,740 | $388.29 | +$5.34M | 2,038,682 |
| Baker Bros. Advisors Lp | Director | Nov 06 | Open-market buy · P | +60,400 | $383.02 | +$23.1M | 2,024,942 |
| Baker Bros. Advisors Lp | Director | Nov 04 | Open-market buy · P | +10,080 | $368.11 | +$3.71M | 1,964,542 |
| Baker Bros. Advisors Lp | Director | Nov 04 | Open-market buy · P | +5,586 | $366.99 | +$2.05M | 1,954,462 |
| Sibold William John | President and CEO | Sep 11 | Open-market sale · S | −120 | $546.38 | −$65.6K | 197,746 |
| Sibold William John | President and CEO | Sep 11 | Open-market sale · S | −761 | $544.83 | −$415K | 197,866 |
| Sibold William John | President and CEO | Sep 11 | Open-market sale · S | −1,539 | $544.02 | −$837K | 198,627 |
| Sibold William John | President and CEO | Sep 11 | Open-market sale · S | −1,202 | $542.60 | −$652K | 200,166 |
| Sibold William John | President and CEO | Sep 11 | Open-market sale · S | −368 | $541.64 | −$199K | 201,368 |
| Sibold William John | President and CEO | Sep 11 | Open-market sale · S | −687 | $540.59 | −$371K | 201,736 |
| Sibold William John | President and CEO | Sep 11 | Open-market sale · S | −160 | $537.62 | −$86K | 202,423 |
| Sibold William John | President and CEO | Sep 11 | Open-market sale · S | −218 | $535.94 | −$117K | 202,583 |
| Sibold William John | President and CEO | Sep 11 | Open-market sale · S | −106 | $534.06 | −$56.6K | 202,801 |
| Sibold William John | President and CEO | Sep 11 | Open-market sale · S | −60 | $533.09 | −$32K | 202,907 |
| Sibold William John | President and CEO | Sep 09 | Open-market sale · S | −160 | $542.55 | −$86.8K | 202,967 |
| Sibold William John | President and CEO | Sep 09 | Open-market sale · S | −362 | $541.65 | −$196K | 203,127 |
| Sibold William John | President and CEO | Sep 09 | Open-market sale · S | −505 | $540.19 | −$273K | 203,489 |
| Sibold William John | President and CEO | Sep 09 | Open-market sale · S | −215 | $539.03 | −$116K | 203,994 |
Loading...